Reperfusion injury: Basic concepts and protection strategies

Journal of Thrombosis and Thrombolysis

Volumn 4, Issue 1, 1997, Pages 7-24

  Kukreja, Rakesh C ^a   Janin, Yves ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Calcium; Ischemia; Lipid peroxidation; Reperfusion injury

Indexed keywords

CALCIUM; FREE RADICAL; HYDROXYL RADICAL; OXYGEN RADICAL;

ARTICLE; CALCIUM CELL LEVEL; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; LIPID PEROXIDATION; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0031025378     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1017569611074     Document Type: Article

References (178)

1. Braunwald E, Kloner RA. Myocardial reperfusion: A double-edged sword. J Clin Invest 1985;76:1713-1719.
2. Jennings RB, Sommers HM, Smyth GA, Flack HA, Linn H. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Pathology 1960;70:68-78.
3. Bulkley BH, Hutchins GM. Myocardial consequences of coronary artery bypass graft surgery: The paradox of necrosis in areas of revascularization (abstr). Circulation 1977;56:906-913.
4. Greene HL, Weisfeldt ML. Determinants of hypoxic and post-hypoxic myocardial contacture. Am J Physiol 1977;232:H526-H533.
5. Shine KI, Douglas AM. Low calcium reperfusion of ischemic myocardium. J Mol Cell Cardiol 1983;15:251-260.
6. Hess ML, Manson NH. Molecular oxygen: Friend or foe. J Mol Cell Cardiol 1984;16:99-985.
7. Bolli R. Oxygen-derived free radicals and myocardial reperfusion injury: An overview. Cardiovasc Drugs Ther 1991;5:249-268.
8. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
9. Fridovich I. The biology of oxygen radicals. Science 1978; 201:875-880.
10. McCord JM, Fridovich I. The biology and pathology of oxygen radicals. Ann Intern Med 1978;89:122-127.
11. Chambers DE, Parks DA, Patterson G, et al. Xanthine oxidase as a source of free radical damage in myocardiac ischemia. J Mol Cell Cardiol 1985;17:145-152.
12. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. Free Radic Biol Med 1985;312:159-163.
13. McCord JM, Roy RS, Schaffer SW. Free radicals and myocardial ischemia. The role of xanthine oxidase. Adv Myocardiol 1985;5:183-189.
14. McCord JM. Oxygen-derived radicals: A link between reperfusion injury and inflammation. Fed Proc 1987;46:2402-2406.
15. Freeman BA, Crapo JD. Biology of disease. Free radicals and tissue injury. Lab Invest 1982;47:412-426.
16. Singal PK, Kapur N, Dhillon KS, Beamish RE, Dhalla NS. Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol 1982;60:1390-1397.
17. Kukreja RC, Kontos HA, Hess ML, Ellis EF. PGH synthase and lipoxygenase generate Superoxide in the presence of NADH or NADPH. Circ Res 1986;59:612-619.
18. Garlick PB, Davies MJ, Hearse DJ, Slater TF. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 1987;61:757-760.
19. Blasig IE, Ebert B, Wallukat G, Loewe H. Spin trapping evidence for radical generation by isolated hearts and cultured heart cells. Free Radic Res Commun 1990;6:303-310.
20. Sekizuka E, Benoit JN, Grisham MB, Granger DN. Dimethylsulfoxide prevents chemoattractant-induced leukocyte adherence. Am J Physiol 1989;256:H594-H597.
21. Tappel AL. Measurement of and protection from in vivo lipid peroxidation. In: Zimmerman RS, ed. Free Radicals in Biology. Orlando, FI: Academic Press, 1980:1-19.
22. Kellogg EW. Superoxide, hydrogen peroxide and singlet oxygen in lipid peroxidation by a xanthine oxidase system. J Biol Chem 1975;250:8812-8817.
23. Mead JF. Free radical mechanisms in lipid peroxidation and prostaglandins. In: Free Radicals in Molecular Biology and Disease. New York: Raven Press, 1984:53-65.
24. Tappel AL. Lipid peroxidation damage to cell components. Fed Proc 1973;32:1870-1874.
25. Shen AC, Jennings RB. Kinetics of calcium accumulation in acute myocardial ischemic injury. Am J Pathol 1972;67:441-416.
26. Shen AC, Jennings RB. Myocardial calcium and magnesium in acute ischemic injury. Am J Pathol 1972;67:417-422.
27. Jennings RB, Reimer KA, Steenbergen CJ. Myocardial ischemia revisited: The osmolar load, membrane damage and reperfusion. J Mol Cell Cardiol 1986;18:769-780.
28. Marban E, Koretsune Y, Corretti M, Chacko VP, Kusuoka H. Calcium and its role in myocardial cell injury during ischemia reperfusion. Circulation 1989;80:4:17-22.
29. 2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest 1987;79:950-961.
30. Kitakaze M, Weisman HF, Marban E. Contractile dysfunction and ATP depletion after transient calcium overload in perfused ferret hearts. Circulation 1988;77:685-695.
31. 2+ transients underlie stunning? Circ Res 1990;66:1268-1276.
32. Weisel RD, Mickle DAG, Finkle CD, et al. Myocardial free-radical injury after cardioplegia. Circulation 1989; 80(Suppl III):14-18.
33. Romaschin AD, Rebeyka I, Wilson GJ, Mickle DAG. Conjugated dienes in ischemic and reperfused myocardium: An in vivo chemical signature of oxygen free radical mediated injury. J Mol Cell Cardiol 1987;19:289-302.
34. Thompson JA, Hess ML. The oxygen free radical system: A fundamental mechanism in the production of myocardial necrosis. Prog Cardiovasc Dis 1986;28:449-462.
35. Kaneko M, Beamish RE, Dhalla NS. Depression of heart sarcolemmal Ca-pump activity by oxygen free radicals. Am J Physiol 1989;256:H368-H374.
36. 2+ pump by oxygen free radicals. Am J Physiol 1989;26:H804-H811.
37. Opie LH. Reperfusion injury and its pharmacologic modifications. Circulation 1989;80:1049-1062.
38. Owen P, Dennis S, Opie LH. Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. Circ Res 1990;66:344-345.
39. Paul RJ. Smooth muscle energetics. Annu Rev Physiol 1989;51:331-349.
40. Jeremy RW, Koretsune Y, Marban E, Becker LC. Relation between glycolysis and calcium homeostasis in postischemic myocardium. Circ Res 1992;70:1180-1190.
41. Chatham J, Gilbert HF, Radda GK. The metabolic consequences of hydroperoxide perfusion on the isolated rat heart. Eur J Pharmacol 1989;184:657-662.
42. Corretti MC, Koretsune Y, Kusuoka H, Chacko VP, Zweier JL, Marban E. Gyocolytic inhibition and calcium overload as consequences of exogenously generated free radicals in rabbit hearts. J Clin Invest 1991;88:1014-1025.
43. Burton KP, McCord JM, Ghai G. Myocardial alterations due to free-radical generation. Am J Physiol 1984;246:H776-H783.
44. Blaustein AS, Schine L, Brooks WW, Fanburg BL, Bing OHL. Influence of exogenously generated oxdidant species on myocardial function. Am J Physiol 1986;250:H595-H599.
45. Schrier GM, Hess ML. Quantitative identification of superoxide anion as a negative inotropic species. Am J Physiol 1988;255:H138-H143.
46. Shattock MJ, Manning AS, Hearse DJ. Effects of hydrogen peroxide on cardiac function and postischemic functional recovery in the isolated "working" rat heart. Pharmacology 1982;24:118-122.
47. Ytrehus K, Myklebust R, Mjos OD. Influence of oxygen radicals generated by xanthine oxidase in the isolated perfused rat heart. Cardiovasc Res 1986;20:597-603.
48. Miki S, Ashraf M, Salka S, Sperelakis N. Myocardial dysfunction and ultrastructural alterations mediated by oxygen metabolites. J Mol Cell Cardiol 1988;20:1009-1024.
49. 2 free radical-mediated myocardial and vascular dysfunction. Am J Physiol 1986;251:H1225-H1231.
50. Goldhaber JI, Lamp ST, Weiss JN. Effects of exogenous free radicals on electrochemical function and metabolism in isolated rabbit and guinea pig ventricle. J Clin Invest 1989;83:1800-1809.
51. Przyklenk K, Whittaker P, Kloner RA. In vivo infusion of oxygen free radical substrates causes myocardial systolic, but not diastolic dysfunction. Am Heart J 1990; 119:807-815.
52. + antagonists. J Mol Cell Cardiol 1988;20:811-823.
53. Hearse DJ, Kusama Y, Bernier M. Rapid electrophysiological changes leading to arrhythmias in the aerobic rat heart: Photo-sensitization studies with rose bengal-derived reactive oxygen intermediates. Circ Res 1989;65:146-153.
54. Kusama Y, Bernier M, Hearse DJ. The exacerbation of reperfusion arrhythmias by sudden oxidant stress. Circ Res 1990;67:481-489.
55. Yamada M, Hearse DJ, Curtis MJ. Reperfusion and read-mission of oxygen. Pathophysiological relevance of oxygen-derived free radicals to arrhythmogenesis. Circ Res 1990;67:1211-1224.
56. Vandeplassche G, Bernier M, Kusama BM, Hearse DJ. Singlet oxygen and myocardial injury: Ultrastructural, cytochemical and electrocardiographic consequences of photoactivation of rose bengal. J Mol Cell Cardiol 1990;22:287-301.
57. Shattock MJ, Matsuura H, Hearse DJ. Functional and electrophysiological effects of oxidant stress on isolated ventricular muscle: A role for oscillatory calcium release from sacroplasmic reticulum in arrhythmogenesis? Cardiovasc Res 1991;25:645-651.
58. Kazziha SY, Kraus S, Loesser KE, Hess ML. Photosensitizer studies with rose bengal-derived reactive oxygen intermediates on isolated papillary rat heart muscle. FA-SEB J 1991;5:A1282.
59. Shattock MJ, Matsuura H, Hearse DJ. Functional and electrophysiological effects of oxidant stress on isolated ventricular muscle: A role for oscillatory calcium release from the sarcoplasmic reticulum in arrhythmogenesis? Cardiovasc Res 1991;25:645-651.
60. Tarr M, Valenzeno DP. Modification of cardiac action potential by photosensitizer-generated reactive oxygen. J Mol Cell Cardiol 1989;21:539-543.
61. Stuart J, Pessah IN, Favero TG, Abramson JJ. Photooxidation of skeletal muscle sarcoplasmic reticulum induces rapid calcium release. Arch Biochem Biophys 1992;292:512-521.
62. Itoh S, Yanagishita M, Tomita M, et al. Detection of free radicals during reperfusion injury in dog heart. J Mol Cell Cardiol 1991;23(Suppl):S42.
63. Konno N, Yanagishita T, Geshi E, Katagirl T. Degradation of the cardiac sarcoplasmic reticulum in acute myocardial ischemia. Jpn Circ J 1987;51:411-420.
64. +-ATPaSe. Am J Physiol 1987;252:H252-H257.
65. Limbruno U, Zucchi R, Ronca-Testoni S, Galbani P, Ronca G, Mariani M. Sarcoplasmic reticulum function in the "stunned" myocardium. J Mol Cell Cardiol 1989;21:1063-1072.
66. 2+-ATPaSe of cardiac sarcoplasmic reticulum. Circ Res 1991;69:1003-1014.
67. Holmberg SRM, Cumming DVE, Kusama Y, et al. Reactive oxygen species modify the structure and function of the cardiac sarcoplasmic reticulum calcium-release channel. Cardioscience 1991;2:19-25.
68. Jennings RB, Steenburgen CJ, Reimer KA. Myocardial ischemia and reperfusion. Monogr Pathol 1995;37:47-80.
69. Werns SW, Shea MJ, Driscoll EM, et al. The independent effects of oxygen radical scavengers on canine infarct size. Reduction by superoxide dismutase, but not catalase. Circ Res 1985;56:895-898.
70. Uraizee A, Reimer KA, Murry CE. Failure of Superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs. Circulation 1987;75:1237-1248.
71. Gallagher KP, Buda AJ, Pace D. Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion. Circulation 1986;73:1065-1076.
72. Jolly SR, Kane WJ, Bailie MB, Abrams GD, Lucchesi BR. Canine myocardial reperfusion injury; its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 1984;54:277-285.
73. Nejimia J, Knight DR, Fallon JT, et al. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs. Circulation 1989;79:143-153.
74. Ambrosio G, Weisfeldt ML, Jacobus WE, Flaherty JT. Evidence of a reversible oxygen radical-mediated component of a reperfusion injury: reduction by recombinant human superoxide dismutase adminsitered at the time of reflow. Circulation 1987;75:282-291.
75. Miura T, Downey JM, Hotta II D, Iimura O. Effect of superoxide dismutase plus catalase on myocardial infarct size in rabbits. Can J Cardiol 1988;4:407-411.
76. Ambrosio G, Becker LC, Hutchins GM, Weisman HF, Weisfeldt ML. Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury. Circulation 1986;74:1424-1433.
77. Klein HH, Puschmann S, Shaper J, Schaper W. The mechanism of the tetrazolium reaction in identifying myocardial infarction. Virch Arch 1981;393:287-297.
78. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-1508.
79. Schoffer J, Montz R, Mathey D. Scintigraphic evidence of the 'no-reflow' phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol 1985;5:593-598.
80. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis: A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992; 85:1699-1705.
81. Abbo KM, Dooris M, Glazier S, et al. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol 1995;75:778-782.
82. Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994;89:2514-2518.
83. Morishima I, Sone T, Mokuno S, et al. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J 1995;130:239-243.
84. Becker LC, Ambrosio G. Myocardial consequences of reperfusion. Prog Cardiovasc Dis 1987;30:23-44.
85. Engler RL, Dahlgren MD, Morris DD. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 1986;251:H314-H322.
86. Kloner RA, Alker K, Campbell C, Figures G, Eisenhauer A, Hale S. Does tissue-type plasminogen activator have direct beneficial effects on the myocardium independent of its ability to lyse intracoronary thrombi? Circulation 1989;79:1125-1136.
87. Mehta JL, Nichols WW, Donnelly WH, Lawson DL, Saldeen TGP. Impaired canine coronary vasodilator response to acetylcholine and bradykinin after occlusionreperfusion. Circ Res 1989;64:43-54.
88. Pique JM, Whittle BJR, Esplugues JV. The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation. Eur J Pharmacol 1989;174:293-296.
89. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;2:997-1000.
90. Kostic MM, Schrader J. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res 1992;70:208-212.
91. Breslow MJ, Tobin JR, Bredt DS, Ferris CD, Snyder SH, Traystman RJ. Role of nitric oxide in renal medullary vasodillation during catecholamine secretion. Eur J Pharmacol 1992;210:105-106.
92. Pelc LR, Gross GL, Warltier DC. Preferential increase in subendocardial perfusion produced by endothelium-dependent vasodilators. Circulation 1987;76:191-200.
93. Kozniewska E, Oseka M, Stys T. Effects of endotheliumderived nitric oxide on cerebral circulation during normoxia and hypoxia in the rat. J Cereb Blood Flow Metab 1992;12:311-317.
94. Palmer RMJ, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988;153:1251-1256.
95. Myers PR, Minor RL Jr, Guerra Jr, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 1990;345:161.
96. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007-2018.
97. Ku DD. Coronary vascular reactivity after acute myocardial ischemia. Science 1982;218:576-578.
98. Tsao PS, Aoki N, Lefer DJ, Johnson III, G, Lefer AM. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 1990;82:1402-1412.
99. Mehta JL, Nichols WW, Donnelly WM, Lawson DL, Saldeen TGP. Impaired canine responses to acetylcholine and bradykinin after occlusion-reperfusion. Circ Res 1993;64:43-54.
100. Armstrong PW, Walker DC, Burton JR, Parker JO. Vasodilator therapy in acute myocardial infarction: A comparison of sodium nitroprusside and nitroglycerin. Circulation 1975;52:1118-1122.
101. Bussman WD, Passek D, Seidel W, Kaltenbach M. Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin. Circulation 1981;63:615-622.
102. Flaherty JT, Becker LC, Bulkly BH, et al. A randomized prospective trial of intravenous nitroglycerin in patients with acute myocardial infarction. Circulation 1993;68:576-588.
103. Johnson GI, Tsao PS, Mulloy D, Lefer AM. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther 1990;252:35-41.
104. Johnson III G, Tsao PS, Lefer AM. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 1991;19:244-252.
105. Siegfried MR, Erhardt J, Rider T, Ma XL, Lefer AM. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemiareperfusion. J Pharmacol Exp Ther 1992;260:668-675.
106. Weyrich AS, Ma XL, Lefer AM. The role of 1-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992;86:279-288.
107. Schlüter KD, Weber M, Schraven E, Piper HM. NO donor SIN-1 protects against reoxygenation induced cardiomyicyte injury by a dual action. Am J Physiol 1994;267:H1461-H1466.
108. Zweier JL. Measurement of superoxide-derived free radicals in the reperfused heart. J Biol Chem 1988;263:1353-1357.
109. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991;288:481-487.
110. Matheis G, Sherman MP, Buckberg GD, Haybron DM, Young HH, Ignarro LJ. Role of 1-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992;262:H616-H620.
111. Myers ML, Bolli R, Lekich RF, Hartley CJ, Michael LH, Roberts R. N-2-mercaptopropionylglycine improves recovery of myocardial function following reversible regional ischemia. J Am Coll Cardiol 1986;8:1161-1168.
112. Brown JM, Grosso MA, Tarada GJ, et al. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat heart. Proc Natl Acad Sci USA 1989;86:2516-2520.
113. Pearson PJ, Lin PJ, Schaff HV. Production of endothelium derived contracting factor is enhanced after coronary reperfusion. Ann Thorac Surg 1991;288:481-487.
114. Naseem SA, Kontos MC, Rao PS, Jesse RL, Hess ML, Kukreja RC. Sustained inhibition of nitric oxide by NG-nitro-1-arginine improves myocardial function following ischemia/reperfusion in isolated rat heart. J Mol Cell Cardiol 1995;27:419-426.
115. Dauber IM, Van Benthuysen KM, McMurty IF, et al. Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion. Circ Res 1990;66:986-998.
116. Bolli R, Triana JF, Jeroudi MO. Prolonged impairment of coronary vasodilation after reversible ischemia. Evidence for microvascular "stunning." Circ Res 1990;67:332-343.
117. Vanhaecke J, Flameng W, Borgers M, Jong I, Van der Wef F, DeGeest H. Evidence for decreased coronary flow reserve in viable postischemic myocardium. Circ Res 1990;67:1201-1210.
118. Van Benthuysen KM, McMurtry IF, Horowitz LD. Reperfusion after acute coronary occlusion in dogs impairs endothelial dependant relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest 1987;79:265-274.
119. Crea F, Davis G, Crake T, et al. Variability of coronary blood flow reserve assessed by Doppler catheter after successful thrombolysis in patients with acute MI. Am Heart J 1993;125:1547-1552.
120. Manning AS, Coltart DJ, Hearse DJ. Ischemia- and reperfusion-induced arrythymias in the rat: Effects of xanthine oxidase inhibition with allopurinol. Circ Res 1984;55:545-550.
121. Bernier M, Hearse DJ, Manning AS. Reperfusion-induced arrhythmias and oxygen-derived free radicals. Circ Res 1986;58:331-340.
122. Woodward B, Zakaria MNM. Effects of some free radical scavengers on reperfusion-induced arrhythmias in the isolated rat heart. J Mol Cell Cardiol 1985;17:485-499.
123. Manning A, Bernier M, Crome R, Little SH. Reperfusion arrhythmias: A study of the role of xanthine oxidasederived free radicals in the rat heart. J Mol Cell Cardiol 1988;20:35-40.
124. Carbonin P, Gennaro M, di Valle R, Weisz AM. Inhibitory effect of anoxia on reperfusion- and digitalis-induced ventricular tachyarrhythmias. Am J Physiol 1981;240:H730-H737.
125. Corr PB, Witkowski FX. Potential electrophysiologic mechanisms responsible for dysrhythmias associated with reperfusion of ischemic myocardium. Circulation 1983;68(Suppl 1):16-24.
126. Goldberg S, Greenspan AJ, Urban PL, et al. Reperfusion arrhythmias: A marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarction. Am Heart J 1983;105:26-31.
127. Maras P, Della Grazie E, Klugmann S, et al. Reperfusion ventricular arrhythmias during intracoronary thrombolysis. Eur Heart J 1986;7:23-30.
128. Tzivoni D, Kerven A, Granot H, Gottlieb S, Benhorin J, Stern S. Ventricular fibrillation caused by myocardial reperfusion in Prinzmetal's angina. Am Heart J 1983; 105:323-325.
129. Manning AS, Hearse DJ. Reperfusion-induced arrhythmias: Mechanisms and prevention. J Moll Cell Cardiol 1984;16:497-518.
130. Kaplinsky E, Ogawa S, Michelson EL, Dreifus LS. Instantaneous and delayed ventricular arrhythmias after reperfusion of acutely ischemic myocardium: Evidence for multiple mechanisms. Circulation 1981;63:333-340.
131. Bolli R, Patel B. Factors that determine the occurrence of reperfusion arrhythmias. Am Heart J 1988;115:20-29.
132. Tosaki A, Braquet P. DMPO and reperfusion injury: Arrhythmia, heart function, electron spin resonance, and nuclear magnetic resonance studies in isolated working guinea pig hearts. Am Heart J 1990;120:819-830.
133. Pallandi RT, Perry MA, Campbell TJ. Proarrhythmic effects of an oxygen-derived free radical generating system on action potentials recorded from guinea pig ventricular myocardium: A possible cause of reperfusion-induced arrhythmias. Circ Res 1987;61:50-54.
134. Paczkowski J, Lamberts JJM, Paczkowska B, Neckers DC. Photophysical properties of rose bengal and its derivatives. J Free Radic Biol Med 1985;17:485-499.
135. Neckers DC, Paczkowski J. Micro-organizational control of photochemical oxidations: Rose bengal and derivatives. Tetrahedron 1986;42:4671-4683.
136. Lee PC, Rodgers AJ. Laser flash photokinetic studies of rose bengal sensitized photodynamic interactions of nucleotides and DNA. Photochem Photobiol 1987;45:79-86.
137. Hearse DJ, Tosaki A. Reperfusion-induced arrhythmias and free radicals: Studies in the rat heart with D.M.P.O. J Cardiovasc Pharm 1987;9:641-650.
138. Bernier M, Manning AS, Hearse DJ. Reperfusion arrhythmias: Dose-related protection by anti-free radical interventions. Am J Physiol 1989;25:H1344-H1352.
139. Coetzee WA, Owen P, Dennis SC, Saman S, Opie LH. Reperfusion damage: Free radicals mediate delayed membrane changes rather than early ventricular arrhythmias. Cardiovasc Res 1990;24:156-164.
140. Maxwell MP, Hearse DJ, Yellon DM. Inability of desferrioxamine to limit tissue injury in the ischaemic and reperfused rabbit heart. J Cardiovasc Pharmacol 1989;13:608-615.
141. Maupoil V, Rochette L. Evaluation of free radical and lipid peroxide formation during global ischaemia and reperfusion in isolated perfused rat heart. Cardiovasc Drugs Ther 1988;2:601-607.
142. Yellon DM, Downey JM. Current research views on myocardial reperfusion and reperfusion injury. Cardioscience 1990;1:89-98.
143. Bolli R. Oxygen-derived free radicals and postischemic myocardial dysfunction ("stunned myocardium"). J Am Coll Cardiol 1988;12:239-249.
144. Bolli R. Mechanism of myocardial "stunning." Circulation 1990;82:723-738.
145. Patel B, Kloner RA, Przyklenk K, Braunwald E. Postischemic myocardial "stunning": A clinically relevant phenomenon. Ann Intern Med 1988;108:626-628.
146. Braunwald E, Kloner RA. The stunned myocardium. Prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-1149.
147. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB. Demonstration of free radical generation in stunned myocardium of intact dogs with the use of the spin trap a-phenyl N-tert-butyl nitrone. J Clin Invest 1988;82:476-485.
148. Leiboff RL, Arroyo CM, Schaer GL, et al. Free radical generation in an in vivo model of regional myocardial stunning (abstr). FASEB J 1988;2:A818.
149. Belli R, Jeroudi MO, Patel BS, et al. Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci USA 1989;86:4695-4699.
150. Bolli R, Jeroudi MO, Patel BS, et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion: Evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res 1989;65:607-622.
151. Myers ML, Bolli R, Lekich RF, Hartley CJ, Roberts R. Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia. Circulation 1985;72:915-921.
152. Bolli R, Zhu W-X, Hartley CJ, et al. Attenuation of dysfunction in the postischemic stunned myocardium by dimethylthiourea. Circulation 1987;76:458-468.
153. Bolli R, Patel BS, Zhu WX, O'Neill PG, Charlat ML, Roberts R. The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction. Am J Physiol 1987;253:H1372-H1380.
154. Farber NE, Vercellotti GM, Jacob HS, Pieper GM, Gross GJ. Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in canine heart. Circ Res 1988;63:351-360.
155. Przyklenk K, Kloner RA. Superoxide dismutase plus catalase improve contractile function in the canine model of the "stunned myocardium." Circ Res 1986;58:148-156.
156. Gross GJ, Farber NE, Hardman HF, Warltier DC. Beneficial actions of superoxide dismutase and catalase in stunned myocardium of dogs. Am J Physiol 1986;250:H372-H377.
157. Triani JF, Unisa A, Bolli R. Antioxidant enzymes attenuate myocardial "stunning" in the conscious dog. FASEB J 1990;4:A622.
158. Heyndrickx GR, Millard RW, McRitchi RJ, Maroko PR, Vatner SF. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975;56:978-985.
159. Przyklenk K, Kloner RA. Reperfusion injury by oxygenderived free radicals. Circ Res 1989;64:86-96.
160. Wynsen J, Preuss KC, Gross GJ, Brooks HL, Warltier DC. Steroid-induced enhancement of functional recovery of postischemic, reperfused, myocardium in conscious dogs. Am Heart J 1988;116:915-925.
161. Przyklenk K, Kloner RA. Effect of verapamil on postischemic "stunned" myocardium: Importance of timing of treatment. J Am Coll Cardiol 1988;11:614-623.
162. Przyklenk K, Ghafari GB, Eitzman DT, Kloner RA. Nifedipine administered after reperfusion ablates systolic eontractile dysfunction of postischemic "stunned" myocardium. J Am Coll Cardiol 1989;13:1176-1183.
163. Taylor AE, Golino P, Eckels R, Pastor P, Buja LM, Willerson JT. Differential enhancement of postischemic segmental systolic thickening by diltiazem. J Am Coll Cardiol 1990;15:737-747.
164. Westlin W, Mullane K. Does captopril attenuate reperfusion induced myocardial dysfunction by scavenging free radicals. Circulation 1988;77(Suppl):I30-I39.
165. Przyklenk K, Whittaker P, Kloner RA. Zofenopril, a newly developed sulfhydryl-containing converting enzyme inhibitor, enhances contractile function of "stunned" myocardium. In: MacGregor GA, Sever PS, eds. Current Advances in ACE Inhibition. Edinburgh: Churchill Livingstone, 1989:279.
166. Blaustein A, Deneke SM, Stolz RI, Baxter D, Healey N. Fanburg BL. Myocardial glutathione depletion impairs recovery after short periods of ischemia. Circulation 1989;80:1449-1457.
167. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
168. Currie RW. Effects of ischemia and perfusion temperature on the synthesis of stress induced (heat shock) proteins in isolated and perfused hearts. J Mol Cell Cardiol 1987;19:795-808.
169. Rothman JE. Polypeptide chain binding proteins: Catalysts of protein folding and related processes in cells. Cell 1989;59:591-601.
170. Kuzuya T, Hoshida S, Yamashita N, et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1994;72:1293-1299.
171. Marber MS, Metril R, Chi S, Sayen R, Yellon DM, Dillmann WH. Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 1995;95:1446-1456.
172. Sun J, Tang X, Knowlton AA, Park S, Qiu Y, Belli R. Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 hours after brief ischemia in conscious pigs. J Clin Invest 1995;95:388-403.
173. Karmazyn M, Mailer K, Currie RW. Acquisition and decay of heat-shock enhanced postischemic ventricular recovery. Am J Physiol 1990;259:H424-H431.
174. Plumier JL, Ross BM, Currie RW, et al. Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest 1995;95:1854-1860.
175. Kukreja RC, Qian Y, Kontos MC, Hess ML. Quercetin blocks ischemic tolerance and synthesis of HSP 70 in rat heart. J Cell Biochem 1995;19B:219.
176. Qian Y, Kontos MC, Gu Y, Kukreja RC. Quercetin blocks ischemic tolerance in heat stressed rat hearts. Circulation 1994;90:I536.
177. Kukreja RC, Hess ML. Free Radicals, Cardiovascular Dysfunction and Protection Strategies. Austin, TX: R. G. Landes, 1994, in press.
178. Bolli R, Zhu WX, Thornby JI, O'Neill PG, Roberts R. Time-course and determinants of recovery of function after reversible ischemia in concious dogs. Am J Physiol 1988;254:H102-H114.